Because the incidence of pyoderma gangrenosum (PG) is low, no prospective randomized
controlled trials and only a few studies with case numbers of more than 15 patients have …

Pyoderma gangrenosum (PG) is a rare, chronic neutrophilic dermatosis of unknown
etiology. The world wide incidence is estimated to be around 3-10 cases per million …

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by painful,
necrotic ulceration. It typically affects patients in the third to sixth decades of life, with almost …

Critical to the proper management of pyoderma gangrenosum are correct diagnosis,
identification and treatment of any underlying disorder, and the proper choice of topical and …

Pyoderma gangrenosum is a rare and often painful skin disease that can be unpredictable
in its response to treatment. There is currently no gold standard of treatment or published …

Background Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with substantial
morbidity. There is no consensus on gold‐standard treatments. Objectives To review the …

Background Pyoderma gangrenosum (PG) is an uncommon dermatosis with a limited
evidence base for treatment. Objective We sought to estimate the effectiveness of topical …

Pyoderma gangrenosum (PG) is a rare disease, but commonly related to important
morbidity. PG was first assumed to be infectious, but is now considered an inflammatory …

Pyoderma gangrenosum (PG) is an orphan disease. While research on such disorders is
based on only few randomized multicenter as well as retrospective studies, most of the data …

Background: Pyoderma gangrenosum (PG) is an idiopathic ulcerative neutrophilic
inflammatory skin disease characterized by variable clinical presentation and outcome …